2 years ago
BKNG
AnalystsEdward WooEdward Woo's Stock Forecasts
AnalystsEdward Woo
Analyst Ranking
Top 20%
#1030 out of 5134 analysts
Average Return
+3.07%
Win Rate
40%86 out of 214
Risk vs Reward
Poor
Good
Edward Woo's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Streamex CorpSTEX | +707.12% | $0.53 | $4.31 | 2025-04-21 - 2025-12-05 | Buy |
Aim Immunotech IncAIM | +595.40% | $0.35 | $2.42 | 2024-09-03 - 2025-09-02 | Buy |
Quantum Computing IncQUBT | +593.18% | $0.88 | $6.10 | 2023-11-24 - 2024-11-22 | Buy |
Aim Immunotech IncAIM | +533.03% | $0.22 | $1.38 | 2024-12-10 - 2025-12-05 | Buy |
Quantum Computing IncQUBT | +318.80% | $2.66 | $11.14 | 2024-11-13 - 2025-11-12 | Buy |
Edward Woo Analyst Color
Get additional color on Edward Woo's coverage of popular stocks
Edward Woo's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Plus Therapeutics IncPSTV | 6 | Buy | $19.00 | +2,823.08% | Maintains | 18 days ago |
Myomo IncMYO | 6 | Buy | $10.00 | +861.54% | Maintains | 18 days ago |
Renovorx IncRNXT | 7 | Buy | $12.50 | +1,228.37% | Maintains | 18 days ago |
Aemetis IncAMTX | 5 | Buy | $20.00 | +1,215.79% | Maintains | 20 days ago |
TravelzooTZOO | 6 | Buy | $23.00 | +235.28% | Maintains | 20 days ago |
Nrx Pharmaceuticals IncNRXP | 6 | Buy | $47.00 | +1,891.53% | Maintains | a month ago |
Knightscope IncKSCP | 4 | Buy | $27.00 | +469.62% | Maintains | 2 months ago |
Intrusion IncINTZ | 5 | Buy | $12.00 | +705.37% | Maintains | 2 months ago |
Genasys IncGNSS | 4 | Buy | $5.75 | +144.68% | Maintains | 2 months ago |
Lucid Diagnostics IncLUCD | 7 | Buy | $8.00 | +676.70% | Maintains | 2 months ago |
Pavmed IncPAVM | 7 | Buy | $20.00 | +5,979.03% | Maintains | 2 months ago |
Aim Immunotech IncAIM | 3 | Buy | $24.00 | +1,639.13% | Maintains | 2 months ago |
Society Pass IncorporatedSOPA | 6 | Buy | $18.00 | +1,100.00% | Maintains | 2 months ago |
Banzai International IncBNZI | 6 | Buy | $30.00 | +2,379.34% | Maintains | 2 months ago |
Quantum Computing IncQUBT | 5 | Buy | $40.00 | +211.53% | Maintains | 2 months ago |
Surgepays IncSURG | 8 | Buy | $9.50 | +439.77% | Maintains | 2 months ago |
Allarity Therapeutics IncALLR | 2 | Buy | $9.25 | +711.40% | Maintains | 2 months ago |
Alzamend Neuro IncALZN | 6 | Buy | $42.00 | +1,766.67% | Maintains | 2 months ago |
Aytu Biopharma IncAYTU | 2 | Buy | $12.50 | +463.06% | Maintains | 2 months ago |
Maison Solutions IncMSS | 2 | Buy | $4.25 | +704.92% | Maintains | 2 months ago |
Duos Technologies Group IncDUOT | 7 | Buy | $11.50 | +17.71% | Maintains | 2 months ago |
Endra Life Sciences IncNDRA | 4 | Buy | $38.00 | +537.58% | Maintains | 3 months ago |
Gri Bio IncGRI | 4 | Buy | $35.00 | +1,599.03% | Maintains | 3 months ago |
Sintx Technologies IncSINT | 3 | Buy | $25.00 | +520.35% | Maintains | 3 months ago |
Outlook Therapeutics IncOTLK | 5 | Buy | $8.00 | +290.24% | Maintains | 3 months ago |
Atossa Therapeutics IncATOS | 6 | Buy | $7.75 | +869.96% | Maintains | 3 months ago |
Igc Pharma IncIGC | 6 | Buy | $4.50 | +1,410.07% | Maintains | 3 months ago |
Cingulate IncCING | 3 | Buy | $62.00 | +1,453.88% | Maintains | 4 months ago |
Phunware IncPHUN | 6 | Buy | $12.50 | +503.86% | Maintains | 6 months ago |
Streamex CorpSTEX | 4 | Buy | $10.00 | +132.02% | Maintains | 6 months ago |
Ton Strategy CoTONX | 4 | Buy | $62.00 | +1,926.14% | Maintains | 6 months ago |
Envoy Medical IncCOCH | 5 | Buy | $9.50 | +1,028.27% | Maintains | 6 months ago |
Pro Dex IncPDEX | 4 | Buy | $56.00 | +39.23% | Maintains | 6 months ago |
Groupon IncGRPN | 8 | Buy | $19.00 | +7.04% | Maintains | 9 months ago |
Daxor CorpDXR | 3 | Buy | $25.00 | +94.55% | Maintains | 9 months ago |
Electronic Arts IncEA | 2 | Buy | $160.00 | -21.54% | Maintains | 9 months ago |
Take Two Interactive Software IncTTWO | 11 | Buy | $270.00 | +8.92% | Maintains | 9 months ago |
Datavault Ai IncDVLT | 3 | Buy | $11.00 | N/A | Maintains | a year ago |
Biolase IncBIOL | 2 | Buy | $2.00 | N/A | Maintains | a year ago |
Mira Pharmaceuticals IncMIRA | 1 | Buy | $11.00 | N/A | Initiates Coverage On | a year ago |
Jakks Pacific IncJAKK | 1 | Buy | $38.00 | N/A | Maintains | 2 years ago |
Booking Holdings IncBKNG | 2 | Buy | $3,900.00 | N/A | Maintains | 2 years ago |
Expedia Group IncEXPE | 1 | Buy | $168.00 | N/A | Maintains | 2 years ago |
Tripadvisor IncTRIP | 1 | Buy | $30.00 | N/A | Maintains | 2 years ago |
Algorhythm Holdings IncRIME | 1 | Buy | $4.00 | N/A | Initiates Coverage On | 2 years ago |
Heartsciences IncHSCS | 1 | Buy | $330.00 | N/A | Initiates Coverage On | 3 years ago |
Vivos Therapeutics IncVVOS | 1 | Buy | $62.50 | N/A | Initiates Coverage On | 3 years ago |
Autoweb IncAUTO | 1 | Hold | $0.39 | N/A | Downgrades | 3 years ago |
Guardion Health Sciences IncGHSI | 1 | Buy | $37.50 | N/A | Initiates Coverage On | 3 years ago |
Blackboxstocks IncBLBX | 1 | Buy | $24.00 | N/A | Initiates Coverage On | 3 years ago |
Novabay Pharmaceuticals IncNBY | 3 | Buy | $4,900.00 | N/A | Maintains | 4 years ago |
Activision Blizzard IncATVI | 3 | Buy | $95.00 | N/A | Maintains | 4 years ago |
Gamestop CorpGME | 8 | Sell | $5.75 | N/A | Maintains | 4 years ago |
Blue Nile IncNILE1 | 1 | Buy | $6.00 | N/A | Initiates Coverage On | 4 years ago |
Imac Holdings IncBACK | 1 | Buy | N/A | N/A | Initiates Coverage On | 6 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.